author-photo

M. T. Buckley

New York University

23

Papers

651

Citations

Citation Trend

Filter By

Papers (23) Sort By

Journal Conference Others

Continuous intravenous infusion (CIVI) topotecan may be safely combined with tipifarnib

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Targeted amplification of delivery to cell surface receptors by dendrimer self-assembly

2014 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (2)
A Phase II Trial of Sorafenib in Metastatic Melanoma with Tissue Correlates

2010 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (92)
Androgen receptor (AR) overexpression and sensitivity to hormones reversed by epigenetic therapy that restores Purα to a transcriptional repressor complex (RC) of AR deregulated in hormone refractory prostate cancer (HRPC)

2008 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A phase I/II study to determine the feasibility and efficacy of the triple combination of oblimersen (OBL), abraxane (ABX), and temozolomide (TMZ) in metastatic melanoma and normal LDH

2008 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
A complex role of insulin-like growth factor binding proteins (IGFBPs) in melanoma

2008 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patients

2008 Journal of Translational Medicine
Show All
- Source
- Cite
- Save
Citations (8)
Phase II trial of sorafenib (S [BAY 43–9006]) in metastatic melanoma (MM) including detection of BRAF with mutant specific-PCR (MS-PCR) and altered proliferation pathways-final outcome analysis

2008 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations

2008 Oncogene
Show All
- Source
- Cite
- Save
Citations (37)
Androgen receptor overexpression in prostate cancer linked to Pur alpha loss from a novel repressor complex.

2008 Cancer Research
Show All
- Source
- Cite
- Save
Citations (49)